The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Sp642
UPDATE ON THE MASH THERAPEUTIC PIPELINE: FDA APPROVAL?
BACKGROUND AND AIMS: Mitochondrial damage-associated molecular patterns(DAMPs) share structural similarity with bacteria and may trigger potent immune response…